Orexigen Therapeutics, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementOrexigen Therapeutics, Inc. • March 30th, 2017 • Pharmaceutical preparations • New York
Company FiledMarch 30th, 2017 Industry JurisdictionOrexigen Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: